Request for Covid-19 Impact Assessment of this Report
The United States Edaravone Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Edaravone Injection market, reaching US$ million by the year 2028. As for the Europe Edaravone Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Edaravone Injection players cover Mitsubishi Tanabe Pharma, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Edaravone Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
20ml
100ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Mitsubishi Tanabe Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Edaravone Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Edaravone Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Edaravone Injection by Country/Region, 2017, 2022 & 2028
2.2 Edaravone Injection Segment by Type
2.2.1 20ml
2.2.2 100ml
2.3 Edaravone Injection Sales by Type
2.3.1 Global Edaravone Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Edaravone Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Edaravone Injection Sale Price by Type (2017-2022)
2.4 Edaravone Injection Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Edaravone Injection Sales by Application
2.5.1 Global Edaravone Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Edaravone Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Edaravone Injection Sale Price by Application (2017-2022)
3 Global Edaravone Injection by Company
3.1 Global Edaravone Injection Breakdown Data by Company
3.1.1 Global Edaravone Injection Annual Sales by Company (2020-2022)
3.1.2 Global Edaravone Injection Sales Market Share by Company (2020-2022)
3.2 Global Edaravone Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Edaravone Injection Revenue by Company (2020-2022)
3.2.2 Global Edaravone Injection Revenue Market Share by Company (2020-2022)
3.3 Global Edaravone Injection Sale Price by Company
3.4 Key Manufacturers Edaravone Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Edaravone Injection Product Location Distribution
3.4.2 Players Edaravone Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Edaravone Injection by Geographic Region
4.1 World Historic Edaravone Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Edaravone Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Edaravone Injection Annual Revenue by Geographic Region
4.2 World Historic Edaravone Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Edaravone Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Edaravone Injection Annual Revenue by Country/Region
4.3 Americas Edaravone Injection Sales Growth
4.4 APAC Edaravone Injection Sales Growth
4.5 Europe Edaravone Injection Sales Growth
4.6 Middle East & Africa Edaravone Injection Sales Growth
5 Americas
5.1 Americas Edaravone Injection Sales by Country
5.1.1 Americas Edaravone Injection Sales by Country (2017-2022)
5.1.2 Americas Edaravone Injection Revenue by Country (2017-2022)
5.2 Americas Edaravone Injection Sales by Type
5.3 Americas Edaravone Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Edaravone Injection Sales by Region
6.1.1 APAC Edaravone Injection Sales by Region (2017-2022)
6.1.2 APAC Edaravone Injection Revenue by Region (2017-2022)
6.2 APAC Edaravone Injection Sales by Type
6.3 APAC Edaravone Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Edaravone Injection by Country
7.1.1 Europe Edaravone Injection Sales by Country (2017-2022)
7.1.2 Europe Edaravone Injection Revenue by Country (2017-2022)
7.2 Europe Edaravone Injection Sales by Type
7.3 Europe Edaravone Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Edaravone Injection by Country
8.1.1 Middle East & Africa Edaravone Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Edaravone Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Edaravone Injection Sales by Type
8.3 Middle East & Africa Edaravone Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edaravone Injection
10.3 Manufacturing Process Analysis of Edaravone Injection
10.4 Industry Chain Structure of Edaravone Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Edaravone Injection Distributors
11.3 Edaravone Injection Customer
12 World Forecast Review for Edaravone Injection by Geographic Region
12.1 Global Edaravone Injection Market Size Forecast by Region
12.1.1 Global Edaravone Injection Forecast by Region (2023-2028)
12.1.2 Global Edaravone Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Edaravone Injection Forecast by Type
12.7 Global Edaravone Injection Forecast by Application
13 Key Players Analysis
13.1 Mitsubishi Tanabe Pharma
13.1.1 Mitsubishi Tanabe Pharma Company Information
13.1.2 Mitsubishi Tanabe Pharma Edaravone Injection Product Offered
13.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mitsubishi Tanabe Pharma Main Business Overview
13.1.5 Mitsubishi Tanabe Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Edaravone Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Edaravone Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 20ml
Table 4. Major Players of 100ml
Table 5. Global Edaravone Injection Sales by Type (2017-2022) & (K MT)
Table 6. Global Edaravone Injection Sales Market Share by Type (2017-2022)
Table 7. Global Edaravone Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Edaravone Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Edaravone Injection Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Edaravone Injection Sales by Application (2017-2022) & (K MT)
Table 11. Global Edaravone Injection Sales Market Share by Application (2017-2022)
Table 12. Global Edaravone Injection Revenue by Application (2017-2022)
Table 13. Global Edaravone Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Edaravone Injection Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Edaravone Injection Sales by Company (2020-2022) & (K MT)
Table 16. Global Edaravone Injection Sales Market Share by Company (2020-2022)
Table 17. Global Edaravone Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Edaravone Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Edaravone Injection Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Edaravone Injection Producing Area Distribution and Sales Area
Table 21. Players Edaravone Injection Products Offered
Table 22. Edaravone Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Edaravone Injection Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Edaravone Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Edaravone Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Edaravone Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Edaravone Injection Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Edaravone Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Edaravone Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Edaravone Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Edaravone Injection Sales by Country (2017-2022) & (K MT)
Table 34. Americas Edaravone Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Edaravone Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Edaravone Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Edaravone Injection Sales by Type (2017-2022) & (K MT)
Table 38. Americas Edaravone Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Edaravone Injection Sales by Application (2017-2022) & (K MT)
Table 40. Americas Edaravone Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Edaravone Injection Sales by Region (2017-2022) & (K MT)
Table 42. APAC Edaravone Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Edaravone Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Edaravone Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Edaravone Injection Sales by Type (2017-2022) & (K MT)
Table 46. APAC Edaravone Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Edaravone Injection Sales by Application (2017-2022) & (K MT)
Table 48. APAC Edaravone Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Edaravone Injection Sales by Country (2017-2022) & (K MT)
Table 50. Europe Edaravone Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Edaravone Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Edaravone Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Edaravone Injection Sales by Type (2017-2022) & (K MT)
Table 54. Europe Edaravone Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Edaravone Injection Sales by Application (2017-2022) & (K MT)
Table 56. Europe Edaravone Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Edaravone Injection Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Edaravone Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Edaravone Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Edaravone Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Edaravone Injection Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Edaravone Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Edaravone Injection Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Edaravone Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Edaravone Injection
Table 66. Key Market Challenges & Risks of Edaravone Injection
Table 67. Key Industry Trends of Edaravone Injection
Table 68. Edaravone Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Edaravone Injection Distributors List
Table 71. Edaravone Injection Customer List
Table 72. Global Edaravone Injection Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Edaravone Injection Sales Market Forecast by Region
Table 74. Global Edaravone Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Edaravone Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Edaravone Injection Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Edaravone Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Edaravone Injection Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Edaravone Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Edaravone Injection Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Edaravone Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Edaravone Injection Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Edaravone Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Edaravone Injection Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Edaravone Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Edaravone Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Edaravone Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Edaravone Injection Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Edaravone Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Edaravone Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Edaravone Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Mitsubishi Tanabe Pharma Basic Information, Edaravone Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Mitsubishi Tanabe Pharma Edaravone Injection Product Offered
Table 94. Mitsubishi Tanabe Pharma Edaravone Injection Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Mitsubishi Tanabe Pharma Main Business
Table 96. Mitsubishi Tanabe Pharma Latest Developments
List of Figures
Figure 1. Picture of Edaravone Injection
Figure 2. Edaravone Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edaravone Injection Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Edaravone Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Edaravone Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 20ml
Figure 10. Product Picture of 100ml
Figure 11. Global Edaravone Injection Sales Market Share by Type in 2021
Figure 12. Global Edaravone Injection Revenue Market Share by Type (2017-2022)
Figure 13. Edaravone Injection Consumed in Hospital
Figure 14. Global Edaravone Injection Market: Hospital (2017-2022) & (K MT)
Figure 15. Edaravone Injection Consumed in Pharmacy
Figure 16. Global Edaravone Injection Market: Pharmacy (2017-2022) & (K MT)
Figure 17. Global Edaravone Injection Sales Market Share by Application (2017-2022)
Figure 18. Global Edaravone Injection Revenue Market Share by Application in 2021
Figure 19. Edaravone Injection Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Edaravone Injection Revenue Market Share by Company in 2021
Figure 21. Global Edaravone Injection Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Edaravone Injection Revenue Market Share by Geographic Region in 2021
Figure 23. Global Edaravone Injection Sales Market Share by Region (2017-2022)
Figure 24. Global Edaravone Injection Revenue Market Share by Country/Region in 2021
Figure 25. Americas Edaravone Injection Sales 2017-2022 (K MT)
Figure 26. Americas Edaravone Injection Revenue 2017-2022 ($ Millions)
Figure 27. APAC Edaravone Injection Sales 2017-2022 (K MT)
Figure 28. APAC Edaravone Injection Revenue 2017-2022 ($ Millions)
Figure 29. Europe Edaravone Injection Sales 2017-2022 (K MT)
Figure 30. Europe Edaravone Injection Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Edaravone Injection Sales 2017-2022 (K MT)
Figure 32. Middle East & Africa Edaravone Injection Revenue 2017-2022 ($ Millions)
Figure 33. Americas Edaravone Injection Sales Market Share by Country in 2021
Figure 34. Americas Edaravone Injection Revenue Market Share by Country in 2021
Figure 35. United States Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Edaravone Injection Sales Market Share by Region in 2021
Figure 40. APAC Edaravone Injection Revenue Market Share by Regions in 2021
Figure 41. China Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Edaravone Injection Sales Market Share by Country in 2021
Figure 48. Europe Edaravone Injection Revenue Market Share by Country in 2021
Figure 49. Germany Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Edaravone Injection Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Edaravone Injection Revenue Market Share by Country in 2021
Figure 56. Egypt Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Edaravone Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Edaravone Injection in 2021
Figure 62. Manufacturing Process Analysis of Edaravone Injection
Figure 63. Industry Chain Structure of Edaravone Injection
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...